AASLD 2024丨Dr. Qing Xie’s Team: TMF Improves Efficacy and Safety in ALT-Normal Chronic HBV Patients—Midterm Results from the PROMOTE Study
At the 2024 AASLD Annual Meeting, Dr. Qing Xie's team from Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, presented findings on the efficacy and safety of a novel…
